Bechtle Plans To Buy French IT Provider Inmac Wstore; Terms Not Disclosed

German IT company Bechtle AG (BC8G) announced Wednesday its intention to acquire the French IT provider Inmac Wstore S.A.S. The financial terms of the deal were not disclosed.

The companies signed an agreement to this effect, while the law requires consultation of the Inmac Wstore employees' workers council before the signing of the share purchase agreement, the company noted. The acquisition is also subject to customary French regulatory approvals.

Bechtle said the acquisition, if completed, would be the biggest in its history.

Inmac Wstore, which employs more than 400 people, recorded sales of around 420 million euros in 2017. The company has been a part of the American Systemax Group since 2009 and was formed after the merger of Inmac, founded in 1984, and Misco, founded in 1991.

The company sells IT products on the French market under the names In-mac Wstore and Misco. The sale to Bechtle would mean that Systemax would withdraw completely from the IT market.

Thomas Olemotz, CEO, Bechtle AG, said, "This acquisition would be a significant step towards achieving our Vision 2020, which not only provides for a revenue of 5 billion euros and 10,000 employees, but also positions Bechtle as the number 1 in European IT e-commerce."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Consumer Product Safety Commission or CPSC announced recall of thousands of children's Robes made in China and sold exclusively on Amazon.com by various companies. The recalled robes fail to meet the federal flammability standards for children's sleepwear, posing a risk of burn injuries to children. Further, citing the same concerns, Paper Cape children's pajamas manufactured in Peru ... Health services company Cigna Corp. reported Friday higher profit in its fourth quarter reflecting growth in both Evernorth and Cigna Healthcare segments. Adjusted earnings and topline beat market estimates. Looking ahead for fiscal 2023, the company projects adjusted earnings and adjusted revenues to be higher than last year, but below market view. French drug major Sanofi SA reported Friday higher profit in its fourth quarter with strong revenue growth mainly with strong sales of Dupixent. Looking ahead for fiscal 2023, the company projects higher business earnings, but the expected growth is slower than recorded in fiscal 2022. Sanofi shares were losing around 4 percent in the morning trading in Paris as well as in pre-market activity...
Follow RTT